MDS Announces Changes to the Company's Board of Directors
08 Janvier 2007 - 2:00PM
PR Newswire (US)
TORONTO, Jan. 8 /PRNewswire-FirstCall/ -- MDS Inc.
(TSX:MDS)(NYSE:MDZ), a company providing a range of products and
services to the global life sciences markets, announced today that
William D. Anderson, former President of Bell Canada Enterprises
Ventures, will be joining its Board of Directors in February of
this year. Mr. Anderson will bring to the board global business,
finance and tax expertise after having held a variety of executive
positions with Bell Canada Enterprises (BCE) before his retirement
in 2005. At that time, Mr. Anderson was President of BCE Ventures,
where he was responsible for BCE's investments in a number of non
core assets including Telesat Canada Limited, Bell Globemedia Inc.,
and BCE Emergis Inc. He also served as CFO of BCE Inc., CFO of Bell
Canada, CFO of Bell Cablemedia plc in London, England and
Vice-President of Taxation with BCE Inc. Prior to his executive
experiences at BCE, Mr. Anderson, a Chartered Accountant, was a Tax
Partner with KPMG. Mr. Anderson is currently serving as Chairman of
the Board of Directors, Bell Canada International Inc. and as
Chairman of the Audit Committee for TransAlta Corporation. In
addition, he serves on the boards of the Four Seasons Hotel Inc.
and Gildan Activewear Inc. "Bill Anderson's global business
expertise will be an asset as we look to further strengthen the
financial depth on our board," said Stephen P. DeFalco, President
and Chief Executive Officer, MDS Inc. "His financial expertise will
be valuable as we move forward to make disciplined investments to
support our growth strategy." MDS also announced today that Dr. C.
Thomas Caskey has stepped down from the Company's Board of
Directors. Dr. Caskey, who joined the MDS Board in April of 2005,
currently serves as CEO of the Brown Foundation Institute of
Molecular Medicine for the Prevention of Human Diseases (IMM), part
of The University of Texas Health Science Center at Houston. MDS
Inc. (TSX: MDS; NYSE: MDZ) is a global life sciences company that
provides market-leading products and services that our customers
need for the development of drugs and diagnosis and treatment of
disease. We are a leading global provider of pharmaceutical
contract research, medical isotopes for molecular imaging,
radiotherapeutics, and analytical instruments. MDS has more than
8,800 highly skilled people in 28 countries. Find out more at
http://www.mdsinc.com/ or by calling 1-888-MDS-7222, 24 hours a
day. DATASOURCE: MDS Inc. CONTACT: Investor Inquiries, Sharon
Mathers, Vice-President, Investor Relations and External
Communications, (416) 675-6777 ext. 34721, ; Media Inquiries,
Catherine Melville, Director, External Communications, (416)
675-6777 ext. 32265,
Copyright
Mds (NYSE:MDZ)
Graphique Historique de l'Action
De Sept 2024 à Oct 2024
Mds (NYSE:MDZ)
Graphique Historique de l'Action
De Oct 2023 à Oct 2024
Real-Time news about Mds (New York Stock Exchange): 0 recent articles
Plus d'articles sur Mds